Practice question

Answer the question and get instant feedback.

HardEndocrinologyDiabetes Combination Therapyus-usmle-step-2us-usmle-step-3us-abim

A 53-year-old with obesity and type 2 diabetes is on metformin and SGLT2 inhibitor; A1c 7.4%. eGFR 72. To enhance weight loss and glycaemic control, which addition has proven CV benefit?

Practice more on iatroX

Educational content. Not a substitute for clinical judgement or local policy.